Rare diseases
Investigational molecules
Locations
Back to Spain445 clinical trials in Salamanca, Spain across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in SpainEnsayosClinicos.es(opens in a new tab)Cemsidomide and Dexamethasone in Patients with Relapsed or Refractory Multiple Myeloma
SpainJNJ-79635322 versus Teclistamab in Patients with Relapsed or Refractory Multiple Myeloma After at Least 3 Prior Treatments
SpainQTX-2101 and Arsenic Trioxide in Adult Patients With Acute Promyelocytic Leukemia
SpainAZD0120 versus standard regimens in patients with relapsed or refractory multiple myeloma
SpainA study to evaluate the safety and effectiveness of IKT-001 compared to a placebo in adults with pulmonary arterial hypertension.
SpainA Phase 3 Study of Elritercept Versus Epoetin Alfa in ESA‑Naïve Adults with Lower‑Risk Myelodysplastic Syndrome Requiring Red Blood Cell Transfusions
SpainStudy of belantamab mafodotin with drug combination in adults aged 18 years and older with relapsed or refractory multiple myeloma
SpainStudy of blinatumomab and a drug combination for older adults with newly diagnosed Philadelphia-negative B-cell precursor Acute Lymphoblastic Leukemia
SpainStudy of the efficacy and safety of depigmented polymerized grass pollen extracts for patients with allergic rhinitis and controlled asthma.
SpainStudy of Grass Pollen Extract and Olive Pollen Extract for Patients with Hay Fever and Asthma caused by Grass and Olive Pollen Allergies
SpainA study to evaluate the effectiveness and safety of REGN13335 in adults with pulmonary arterial hypertension
SpainA study to evaluate the effectiveness of tenecteplase in patients with acute ischemic stroke who are more than 4.5 hours after their last known well time.
SpainThe busiest research cities in the country
What the registry says about research in the country
Advanced studies focusing on various types of lymphomas and leukemias, including innovative combination therapies for mantle cell lymphoma and chronic myeloid leukemia. Multiple trials are evaluating novel treatment approaches for both newly diagnosed and refractory cases.
Research includes promising treatments for pancreatic adenocarcinoma and advanced breast cancer.
Investigations into preventing and treating respiratory syncytial virus infections, with particular focus on vaccine development for older adults. Studies aim to understand immune responses and evaluate preventive strategies.
Clinical trials emphasize protection for vulnerable populations against respiratory infections.
Research addressing chronic spontaneous urticaria and autoimmune conditions, including innovative treatments for systemic sclerosis. Studies evaluate new therapeutic approaches for inflammatory conditions.
Trials focus on improving patient outcomes through targeted immunological interventions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
